Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: Impact of a pharmacist in a multidisciplinary HF clinic

Journal of Cardiac Failure

Volumn 17, Issue 3, 2011, Pages 217-223

  Gastelurrutia, Paloma ^a,b   Benrimoj, Shalom Isaac ^c   Espejo, José ^d   Tuneu, Laura ^b,d   Mangues, M Antonia ^b   Bayes Genis, Antoni ^a,e  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF GRANADA   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

drug related negative outcomes; drug related problems; Heart failure; pharmaceutical care

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; DRUG USE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHARMACIST; POLYPHARMACY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; AMBULATORY CARE FACILITIES; CARDIOVASCULAR AGENTS; DRUG TOXICITY; FEMALE; HEART FAILURE; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PHARMACISTS; TREATMENT OUTCOME;

EID: 79952185583     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.10.009     Document Type: Article

References (30)

1. M.W. Rich Multidisciplinary heart failure clinics: are they effective in Canada? CMAJ 173 2005 53 54 (Pubitemid 40980941)
2. A. Ducharme, O. Doyon, M. White, J.L. Rouleau, and J.M. Brophy Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial CMAJ 173 2005 40 45 (Pubitemid 40980939)
3. J. Gonseth, P. Guallar-Castillon, J.R. Banegas, and F. Rodriguez-Artalejo The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports Eur Heart J 18 2004 1570 1595 (Pubitemid 39209278)
4. C.O. Phillips, S.M. Wright, D.E. Kern, R.M. Singra, S. Shepperd, and H.R. Rubin Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis JAMA 291 2004 1358 1376
5. F.A. McAlister, S. Stewart, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819 (Pubitemid 39099578)
6. R.L. Howard, A.J. Avery, P.D. Howard, and M. Partridge Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study Qual Saf Health Care 12 2003 280 285 (Pubitemid 36981325)
7. M.I. Baena, M.J. Faus, and P.C. Fajardo Medicine-related problems resulting in emergency department visits Eur J Clin Pharmacol 62 2006 387 393
8. H.S. Blix, K.K. Viktil, and A. Reikvam The majority of hospitalized patients have drug-related problems: results from a prospective study in general hospitals Eur J Clin Pharmacol 60 2004 651 658 (Pubitemid 40064598)
9. S. Varma, J.C. McElnay, C.M. Hughes, A.P. Passmore, and M. Varma Pharmaceutical care of patients with congestive heart failure: interventions and outcomes Pharmacotherapy 19 1999 860 869 (Pubitemid 29415842)
10. K. Patel, S.S. Sansgiry, and L. Miller Pharmacist participation in home health heart-failure programs Am J Health Sys Pharm 60 2003 2259 2260
11. W.A. Gattis, V. Hasselblad, D.J. Whellan, and C.M. O'Connor Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study Arch Intern Med 159 1999 1939 1945 (Pubitemid 29424715)
12. S.L. Koshman, T.L. Charrois, S.H. Simpson, F.A. McAlister, and R.T. Tsuyuki Pharmacist care of patients with heart failure: a systematic review of randomized trials Arch Intern Med 168 2008 687 694 (Pubitemid 351563951)
13. E.E. Roughead, J.D. Barratt, and E. Ramsay The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study Circ Heart Fail 2 2009 424 428
14. Pharmaceutical Care Research Group, University of Granada Pharmacotherapy follow-up: the Dáder method (3rd rev.; 2005) Pharmacy Practice 4 2006 44 53
15. Criteria Committee of the New York Heart Association Nomenclature and criteria for diagnosis of diseases of the heart and great vessels 9th ed. 1994 Little, Brown Boston p. 253-6
16. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130 (Pubitemid 30172933)
17. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 1993 6 13
18. F. Fernández-Llimós, L. Tuneu, M.I. Baena, A. Garcia-Delgado, and M.J. Faus Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems Review. Curr Pharm Des 10 2004 3947 3967 (Pubitemid 39591911)
19. F. Fernandez-Llimos, and M.J. Faus From "drug-related problems" to "negative clinical outcomes." Am J Health Syst Pharm 62 2005 15
20. Niquille A, Bugnon O. Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients. Pharm World Sci 2010;32:512-9.
21. N. Bentsen, and C. Bridges-Webb An international glossary for general/family practice Fam Pract 12 1995 267
22. International Classification of Diseases Available at http://www.who.int/classifications/icd/en Accessed March 31, 2010
23. Available at: http://medical-dictionary.thefreedictionary.com/ intervention. Accessed March 31, 2010.
24. R.J. Cipolle, L.M. Strand, and P.C. Morley Pharmaceutical care practice. Real decreto 711/2002, por el que se regula la farmacovigilancia de medicamentos de uso humano, Boletín oficial del estado, July 7, 1998, 2002, McGraw-Hil New York
25. G.T. Schumock, and J.P. Thorton Focusing on preventability of adverse drug reactions Hosp Pharm 27 1992 538
26. M.I. Baena, R. Marín, J. Martínez Olmos, P. Fajardo, J. Vargas, and M.J. Faus Nuevos criterios para determinar la evitabilidad de los problemas relacionados con los medicamentos. Una revisión actualizada a partir de la experiencia con 2.558 personas Pharm Care Esp 4 2002 393 396 (Pubitemid 36032878)
27. NSAIDs and gastroprotection MeReC briefing no. 20. National Prescribing Centre National Health Service 2002
28. I. Roten, S. Marty, and J. Beney Electronic screening of medical records to detect inpatients at risk of drug-related problems Pharm World Sci 32 2010 103 107
29. D. Rao, A. Gilbert, L. Strand, and R. Cipolle Drug therapy problems found in ambulatory patients populations in Minnesota and South Australia Pharm World Sci 29 2007 647 654 (Pubitemid 47594174)
30. N.M. Albert, C.W. Yancy, L. Liang, X. Zhao, A.F. Hernandez, and E.D. Peterson Use of aldosterone antagonists in heart failure JAMA 302 2009 1658 1665